Icu Medical (ICUI)
Icu Medical on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
1.7M
Short interest
settlement 2026-10-15
7.8
Days to cover
+2.4 days vs prior
73.2%
Short share of volume
2026-11-02
12
Fails to deliver
settlement 2026-10-09
Tue 10 Nov
Next earnings
estimated date
-$6.6M
Insider flow, 90 days
0 buys, 13 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ICUI is 1,712,861 shares, up 197,173 shares over the last month. Over the last 48 readings it ranged from 582,421 shares (15 November 2024) to 1,837,896 shares (29 May 2026). The latest reading sits at the top of that range. At the reported average volume of 219K shares a day that is 7.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/icui" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 1,712,861 | +12.5% | 219,095 | 7.82 |
| 2026-09-30 | 1,523,113 | +0.5% | 280,237 | 5.44 |
| 2026-09-15 | 1,515,688 | +5.8% | 241,127 | 6.29 |
| 2026-08-31 | 1,433,092 | +3.5% | 212,627 | 6.74 |
| 2026-08-14 | 1,384,259 | -0.3% | 387,620 | 3.57 |
| 2026-07-31 | 1,387,706 | -24.3% | 284,963 | 4.87 |
| 2026-07-15 | 1,832,002 | +8.7% | 273,381 | 6.70 |
| 2026-06-30 | 1,685,563 | -4.9% | 369,104 | 4.57 |
| 2026-06-15 | 1,773,120 | -3.5% | 260,030 | 6.82 |
| 2026-05-29 | 1,837,896 | +12.6% | 334,937 | 5.49 |
| 2026-05-15 | 1,632,597 | +0.3% | 292,571 | 5.58 |
| 2026-04-30 | 1,628,295 | +25.2% | 273,067 | 5.96 |
| 2026-04-15 | 1,300,677 | -0.3% | 244,643 | 5.32 |
| 2026-03-31 | 1,304,985 | +9.5% | 305,771 | 4.27 |
| 2026-03-13 | 1,191,690 | +6.1% | 285,715 | 4.17 |
| 2026-02-27 | 1,123,583 | +10.3% | 319,273 | 3.52 |
| 2026-02-13 | 1,018,208 | -10.7% | 261,112 | 3.90 |
| 2026-01-30 | 1,140,705 | -0.7% | 255,079 | 4.47 |
| 2026-01-15 | 1,148,474 | -5.3% | 221,241 | 5.19 |
| 2025-12-31 | 1,212,276 | -7.9% | 207,604 | 5.84 |
| 2025-12-15 | 1,315,759 | -0.6% | 213,254 | 6.17 |
| 2025-11-28 | 1,324,011 | +0.3% | 254,760 | 5.20 |
| 2025-11-14 | 1,319,642 | -12.7% | 376,364 | 3.51 |
| 2025-10-31 | 1,512,385 | +18.0% | 228,137 | 6.63 |
| 2025-10-15 | 1,281,919 | -6.3% | 212,616 | 6.03 |
| 2025-09-30 | 1,368,533 | -5.8% | 308,439 | 4.44 |
| 2025-09-15 | 1,452,107 | +7.5% | 280,486 | 5.18 |
| 2025-08-29 | 1,350,581 | +8.1% | 286,984 | 4.71 |
| 2025-08-15 | 1,249,098 | -1.3% | 467,731 | 2.67 |
| 2025-07-31 | 1,265,230 | +6.8% | 192,156 | 6.58 |
| 2025-07-15 | 1,184,675 | -12.8% | 187,597 | 6.31 |
| 2025-06-30 | 1,359,233 | +24.0% | 260,520 | 5.22 |
| 2025-06-13 | 1,096,338 | +3.3% | 180,204 | 6.08 |
| 2025-05-30 | 1,061,247 | +9.6% | 245,634 | 4.32 |
| 2025-05-15 | 968,671 | +0.1% | 318,618 | 3.04 |
| 2025-04-30 | 967,232 | -8.9% | 262,868 | 3.68 |
| 2025-04-15 | 1,061,482 | +12.9% | 395,315 | 2.69 |
| 2025-03-31 | 940,549 | +9.6% | 263,940 | 3.56 |
| 2025-03-14 | 858,371 | +10.0% | 325,023 | 2.64 |
| 2025-02-28 | 780,222 | -0.8% | 260,560 | 2.99 |
| 2025-02-14 | 786,379 | +7.8% | 158,346 | 4.97 |
| 2025-01-31 | 729,599 | -1.1% | 228,776 | 3.19 |
| 2025-01-15 | 737,756 | -12.0% | 179,651 | 4.11 |
| 2024-12-31 | 838,137 | +14.0% | 224,463 | 3.73 |
| 2024-12-13 | 735,441 | +11.9% | 196,195 | 3.75 |
| 2024-11-29 | 657,448 | +12.9% | 236,183 | 2.78 |
| 2024-11-15 | 582,421 | -10.7% | 290,087 | 2.01 |
| 2024-10-31 | 652,487 | -7.2% | 155,266 | 4.20 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of ICUI volume is 73.2%, down 4.6 points over the last five sessions. Over the last 30 readings it ranged from 53.5% (22 September 2026) to 92.0% (14 October 2026). The latest reading is in line with the 30-session average of 72.0%, on 88K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 65K | 88K | 73.2% | 0 |
| 2026-10-30 | 61K | 81K | 74.4% | 0 |
| 2026-10-29 | 49K | 72K | 68.3% | 0 |
| 2026-10-28 | 33K | 50K | 65.8% | 0 |
| 2026-10-27 | 54K | 97K | 55.3% | 0 |
| 2026-10-26 | 44K | 56K | 77.9% | 0 |
| 2026-10-23 | 63K | 103K | 60.6% | 0 |
| 2026-10-22 | 65K | 79K | 81.9% | 0 |
| 2026-10-21 | 74K | 83K | 89.8% | 0 |
| 2026-10-20 | 52K | 58K | 90.0% | 0 |
| 2026-10-19 | 41K | 50K | 83.4% | 0 |
| 2026-10-16 | 60K | 76K | 79.5% | 0 |
| 2026-10-15 | 79K | 96K | 81.6% | 78 |
| 2026-10-14 | 83K | 91K | 92.0% | 0 |
| 2026-10-13 | 72K | 91K | 79.1% | 0 |
| 2026-10-12 | 66K | 79K | 83.2% | 0 |
| 2026-10-09 | 46K | 58K | 80.2% | 0 |
| 2026-10-08 | 43K | 59K | 73.0% | 0 |
| 2026-10-07 | 46K | 74K | 62.0% | 0 |
| 2026-10-06 | 62K | 78K | 79.3% | 0 |
| 2026-10-05 | 44K | 59K | 74.8% | 0 |
| 2026-10-02 | 66K | 86K | 76.5% | 891 |
| 2026-10-01 | 58K | 108K | 54.2% | 0 |
| 2026-09-30 | 73K | 128K | 57.2% | 10 |
| 2026-09-29 | 82K | 126K | 64.8% | 93 |
| 2026-09-28 | 89K | 139K | 64.0% | 474 |
| 2026-09-25 | 45K | 76K | 59.3% | 0 |
| 2026-09-24 | 106K | 158K | 67.3% | 0 |
| 2026-09-23 | 85K | 148K | 57.2% | 0 |
| 2026-09-22 | 50K | 93K | 53.5% | 2 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in ICUI is 12 shares, down 3 shares over the last settlement date. Over the last 30 readings it ranged from 11 shares (21 May 2026) to 26,400 shares (22 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 12 | $157.18 | $2K |
| 2026-09-30 | 15 | $163.44 | $2K |
| 2026-09-22 | 697 | $155.22 | $108K |
| 2026-09-14 | 152 | $156.48 | $24K |
| 2026-09-10 | 935 | $161.00 | $151K |
| 2026-09-08 | 26 | $167.58 | $4K |
| 2026-09-04 | 67 | $166.29 | $11K |
| 2026-09-03 | 228 | $169.85 | $39K |
| 2026-09-01 | 95 | $172.95 | $16K |
| 2026-08-31 | 76 | $175.10 | $13K |
| 2026-08-18 | 6,970 | $182.51 | $1.3M |
| 2026-07-27 | 719 | $157.44 | $113K |
| 2026-07-16 | 792 | $157.96 | $125K |
| 2026-07-09 | 267 | $151.89 | $41K |
| 2026-07-08 | 40 | $155.37 | $6K |
| 2026-07-06 | 6,699 | $154.97 | $1.0M |
| 2026-06-30 | 827 | $147.93 | $122K |
| 2026-06-22 | 26,400 | $140.37 | $3.7M |
| 2026-06-02 | 369 | $131.64 | $49K |
| 2026-06-01 | 142 | $135.39 | $19K |
| 2026-05-21 | 11 | $129.31 | $1K |
| 2026-05-19 | 185 | $123.08 | $23K |
| 2026-05-18 | 23 | $118.72 | $3K |
| 2026-05-15 | 70 | $122.99 | $9K |
| 2026-05-13 | 28 | $123.23 | $3K |
| 2026-05-12 | 450 | $124.68 | $56K |
| 2026-05-07 | 564 | $119.59 | $67K |
| 2026-04-21 | 72 | $130.58 | $9K |
| 2026-04-20 | 60 | $129.96 | $8K |
| 2026-04-17 | 15 | $126.04 | $2K |
Insider trades
SEC Form 4, newest first. JSONInsiders at ICUI reported 13 open-market sells worth $6.6M in the last 90 days and no open-market buys. Latest filing: Sanzone Virginia Ruth (VP, General Counsel) on 2026-09-03.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 692 | $171.51 | $119K | 15K |
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 724 | $169.53 | $123K | 15K |
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 1K | $168.44 | $209K | 16K |
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 2K | $167.67 | $369K | 17K |
| 2026-09-01 | Bonnell Brian Michael | Chief Financial Officer | Sell | 6K | $175.00 | $1.1M | 56K |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Sell | 1K | $173.91 | $194K | 62K |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Sell | 5K | $173.44 | $792K | 64K |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Sell | 2K | $172.12 | $329K | 68K |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Sell | 2K | $171.05 | $293K | 70K |
| 2026-08-13 | Woolson Daniel | VP, GM-Infusion Capital | Sell | 5K | $181.33 | $982K | 17K |
| 2026-08-12 | Sousa Ben | Chief Information Officer | Sell | 2K | $178.32 | $401K | 3K |
| 2026-08-11 | Voigtlander Christian B. | Chief Operating Officer | Sell | 9K | $182.93 | $1.6M | 37K |
| 2026-08-11 | FINNEY ELISHA W | Director | Sell | 378 | $182.48 | $69K | 5K |
| 2026-05-22 | Woolson Daniel | President | Sell | 2K | $132.21 | $281K | 22K |
| 2026-05-14 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 2K | $124.08 | $304K | 19K |
| 2026-05-13 | KENNEDY KOLLEEN T | Director | Exercise or conversion | 1K | $0.00 | $0 | 5K |
| 2026-05-13 | Hoffmeister David F | Director | Exercise or conversion | 1K | $0.00 | $0 | 6K |
| 2026-05-13 | Hernandez Laurie | Director | Exercise or conversion | 1K | $0.00 | $0 | 5K |
| 2026-05-13 | Greenberg David C. | Director | Exercise or conversion | 1K | $0.00 | $0 | 9K |
| 2026-05-13 | FINNEY ELISHA W | Director | Exercise or conversion | 1K | $0.00 | $0 | 5K |
| 2026-05-13 | Abbey Donald | Director | Exercise or conversion | 1K | $0.00 | $0 | 6K |
| 2026-05-12 | Greenberg David C. | Director | Sell | 2K | $122.91 | $298K | 8K |
| 2026-05-12 | Greenberg David C. | Director | Exercise or conversion | 2K | $101.06 | $245K | 10K |
| 2026-03-25 | Abbey Donald | Director | Other transaction | 704 | $0.00 | $0 | 4K |
| 2026-03-15 | Sousa Ben | Chief Information Officer | Tax withholding | 718 | $125.85 | $90K | 5K |
| 2026-03-15 | Sousa Ben | Chief Information Officer | Exercise or conversion | 1K | $0.00 | $0 | 6K |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Tax withholding | 2K | $125.85 | $226K | 46K |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 3K | $0.00 | $0 | 48K |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Tax withholding | 6K | $125.85 | $793K | 45K |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 11K | $0.00 | $0 | 51K |
| 2026-03-15 | Woolson Daniel | VP, GM-Infusion Capital | Tax withholding | 1K | $125.85 | $163K | 25K |
| 2026-03-15 | Woolson Daniel | VP, GM-Infusion Capital | Exercise or conversion | 3K | $0.00 | $0 | 26K |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Tax withholding | 897 | $125.85 | $113K | 22K |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Exercise or conversion | 2K | $0.00 | $0 | 23K |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Tax withholding | 3K | $125.85 | $396K | 21K |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Exercise or conversion | 6K | $0.00 | $0 | 24K |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Tax withholding | 3K | $125.85 | $339K | 127K |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Exercise or conversion | 5K | $0.00 | $0 | 130K |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Tax withholding | 9K | $125.85 | $1.2M | 125K |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Exercise or conversion | 17K | $0.00 | $0 | 134K |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 2K | $125.85 | $226K | 72K |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Exercise or conversion | 3K | $0.00 | $0 | 74K |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 6K | $125.85 | $730K | 70K |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Exercise or conversion | 11K | $0.00 | $0 | 76K |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Tax withholding | 529 | $132.00 | $70K | 5K |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Exercise or conversion | 957 | $0.00 | $0 | 5K |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Tax withholding | 4K | $132.00 | $524K | 4K |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Exercise or conversion | 7K | $0.00 | $0 | 8K |
| 2026-03-08 | Voigtlander Christian B. | Chief Operating Officer | Tax withholding | 40K | $132.00 | $5.2M | 40K |
| 2026-03-08 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 72K | $0.00 | $0 | 79K |
| 2026-03-08 | Woolson Daniel | VP, GM-Infusion Capital | Tax withholding | 630 | $132.00 | $83K | 23K |
| 2026-03-08 | Woolson Daniel | VP, GM-Infusion Capital | Exercise or conversion | 2K | $0.00 | $0 | 24K |
| 2026-03-08 | Woolson Daniel | VP, GM-Infusion Capital | Tax withholding | 7K | $132.00 | $908K | 21K |
| 2026-03-08 | Woolson Daniel | VP, GM-Infusion Capital | Exercise or conversion | 16K | $0.00 | $0 | 28K |
| 2026-03-08 | Sanzone Virginia Ruth | VP, General Counsel | Tax withholding | 2K | $132.00 | $233K | 19K |
| 2026-03-08 | Sanzone Virginia Ruth | VP, General Counsel | Exercise or conversion | 3K | $0.00 | $0 | 20K |
| 2026-03-08 | Sanzone Virginia Ruth | VP, General Counsel | Tax withholding | 13K | $132.00 | $1.7M | 17K |
| 2026-03-08 | Sanzone Virginia Ruth | VP, General Counsel | Exercise or conversion | 24K | $0.00 | $0 | 30K |
| 2026-03-08 | Jain Vivek | Chairman and CEO | Tax withholding | 60K | $132.00 | $7.9M | 117K |
| 2026-03-08 | Jain Vivek | Chairman and CEO | Exercise or conversion | 108K | $0.00 | $0 | 177K |
| 2026-03-08 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 40K | $132.00 | $5.2M | 65K |
| 2026-03-08 | Bonnell Brian Michael | Chief Financial Officer | Exercise or conversion | 72K | $0.00 | $0 | 104K |
| 2026-03-07 | Sousa Ben | Chief Information Officer | Tax withholding | 782 | $132.00 | $103K | 1K |
| 2026-03-07 | Sousa Ben | Chief Information Officer | Exercise or conversion | 1K | $0.00 | $0 | 2K |
| 2026-03-07 | Voigtlander Christian B. | Chief Operating Officer | Tax withholding | 2K | $132.00 | $257K | 8K |
| 2026-03-07 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 4K | $0.00 | $0 | 10K |
| 2026-03-07 | Woolson Daniel | VP, GM-Infusion Capital | Tax withholding | 702 | $132.00 | $93K | 12K |
| 2026-03-07 | Woolson Daniel | VP, GM-Infusion Capital | Exercise or conversion | 2K | $0.00 | $0 | 13K |
| 2026-03-07 | Sanzone Virginia Ruth | VP, General Counsel | Tax withholding | 1K | $132.00 | $171K | 7K |
| 2026-03-07 | Sanzone Virginia Ruth | VP, General Counsel | Exercise or conversion | 2K | $0.00 | $0 | 8K |
| 2026-03-07 | Jain Vivek | Chairman and CEO | Tax withholding | 3K | $0.00 | $0 | 69K |
| 2026-03-07 | Jain Vivek | Chairman and CEO | Exercise or conversion | 5K | $0.00 | $0 | 72K |
| 2026-03-07 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 1K | $0.00 | $0 | 33K |
| 2026-03-07 | Bonnell Brian Michael | Chief Financial Officer | Exercise or conversion | 4K | $0.00 | $0 | 34K |
| 2025-11-25 | Woolson Daniel | VP, GM-Infusion Capital | Sell | 3K | $152.35 | $441K | 11K |
| 2025-11-11 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 930 | $142.34 | $132K | 5K |
| 2025-11-11 | FINNEY ELISHA W | Director | Sell | 1K | $140.42 | $180K | 4K |
| 2025-11-11 | FINNEY ELISHA W | Director | Exercise or conversion | 1K | $103.76 | $133K | 5K |
| 2025-09-12 | Jain Vivek | Chairman and CEO | Gift | 64K | $0.00 | $0 | 152K |
| 2025-09-12 | Jain Vivek | Chairman and CEO | Gift | 64K | $0.00 | $0 | 67K |
| 2025-08-27 | Greenberg David C. | Director | Buy | 598 | $126.69 | $76K | 8K |
| 2025-08-27 | Greenberg David C. | Director | Buy | 602 | $126.14 | $76K | 7K |
| 2025-08-14 | Jain Vivek | Chairman and CEO | Buy | 20K | $112.92 | $2.2M | 130K |
| 2025-08-14 | Jain Vivek | Chairman and CEO | Buy | 2K | $112.12 | $267K | 111K |
| 2025-05-30 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 700 | $133.62 | $94K | 6K |
| 2025-05-28 | Voigtlander Christian B. | Chief Operating Officer | Sell | 5K | $128.50 | $641K | 6K |
| 2025-05-28 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 6K | $96.83 | $538K | 11K |
| 2025-05-27 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 6K | $96.83 | $538K | 10K |
| 2025-05-27 | Voigtlander Christian B. | Chief Operating Officer | Sell | 5K | $131.00 | $648K | 6K |
| 2025-05-23 | Voigtlander Christian B. | Chief Operating Officer | Sell | 5K | $130.00 | $645K | 5K |
| 2025-05-23 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 6K | $96.83 | $538K | 10K |
| 2025-05-22 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 6K | $96.83 | $538K | 9K |
| 2025-05-22 | Voigtlander Christian B. | Chief Operating Officer | Sell | 5K | $130.03 | $645K | 4K |
| 2025-05-21 | Voigtlander Christian B. | Chief Operating Officer | Sell | 5K | $133.00 | $654K | 4K |
| 2025-05-21 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 6K | $96.83 | $538K | 9K |
| 2025-05-20 | Voigtlander Christian B. | Chief Operating Officer | Sell | 5K | $137.11 | $668K | 3K |
| 2025-05-20 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 6K | $96.83 | $538K | 8K |
| 2025-05-19 | Voigtlander Christian B. | Chief Operating Officer | Sell | 6K | $138.00 | $767K | 2K |
| 2025-05-19 | Voigtlander Christian B. | Chief Operating Officer | Exercise or conversion | 6K | $96.83 | $538K | 8K |
| 2025-05-19 | FINNEY ELISHA W | Director | Sell | 600 | $138.92 | $83K | 3K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON13 Form 144 notices on file for ICUI worth $8.3M at the prices reported; 7 in the last 90 days worth $6.6M. Latest: VIRGINIA SANZONE filed on 2026-09-03 to sell 4,856 shares ($819K) from 2026-09-03.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-03 | VIRGINIA SANZONEOfficer | 5K | $819K | 0.019% | 2026-09-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-01 | BRIAN BONNELLOfficer | 6K | $1.1M | 0.026% | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-31 | BRIAN BONNELLOfficer | 9K | $1.6M | 0.037% | 2026-08-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-13 | DANIEL WOOLSONOfficer | 5K | $982K | 0.022% | 2026-08-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-12 | BENJAMIN SOUSAOfficer | 2K | $401K | 0.009% | 2026-08-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-11 | CHRISTIAN VOIGTLANDEROfficer | 9K | $1.6M | 0.036% | 2026-08-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-11 | ELISHA W FINNEYDirector | 378 | $69K | 0.002% | 2026-08-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-22 | DANIEL WOOLSONOfficer | 2K | $281K | 0.008% | 2026-05-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-14 | VIRGINIA SANZONEOfficer | 2K | $304K | 0.010% | 2026-05-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-12 | DAVID C GREENBERGDirector | 2K | $298K | 0.010% | 2026-05-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-25 | DANIEL WOOLSONOfficer | 3K | $441K | 0.012% | 2025-11-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | VIRGINIA SANZONEOfficer | 930 | $132K | 0.004% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | ELISHA W FINNEYDirector | 1K | $180K | 0.005% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of ICUI in their latest filing, all on Schedule 13G (passive). The largest reported stake is JANUS HENDERSON GROUP Ltd. at 11.1% of the class (2,781,621 shares), filed 2026-08-13 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 3 | Fuller & Thaler Asset Management, Inc.investment adviser | 1.3M | 5.2% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 12 | JANUS HENDERSON GROUP Ltd.parent holding company | 2.8M | 11.1% | 2026-06-30 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 1.3M | 5.2% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 1.5M | 5.8% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding ICUI at their latest 13F. JSON5 of the 30 tracked managers held ICUI at their latest 13F, $113.3M in total at quarter-end prices. Citadel Advisors is the largest at $78.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 536K | $78.6M | 0.01% | +203K |
| Point72 Asset Management | 2026-06-30 | 165K | $24.3M | 0.03% | +82K |
| AQR Capital Management | 2026-06-30 | 44K | $6.5M | 0.00% | +29K |
| D. E. Shaw & Co. | 2026-06-30 | 20K | $2.9M | 0.00% | new |
| Millennium Management | 2026-06-30 | 7K | $970K | 0.00% | -61K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Icu Medical reported revenue of $551.7M, up 0.5% from the same quarter a year earlier, and net income of $19.1M (0.76 diluted EPS). In FY 2025 it generated $179.8M of operating cash flow and spent $8.8M on buybacks.
- Debt
- $1.23B
- Equity
- $2.15B
- Total assets
- $3.97B
- Shares outstanding
- 25,007,038
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $551.7M | $19.1M | 3.5% | 0.76 |
| Q1 FY 2026 | 2026-03-31 | $530.2M | $30.1M | 5.7% | 1.20 |
| Q4 FY 2025derived | 2025-12-31 | $540.7M | -$15.7M | -2.9% | n/a |
| Q3 FY 2025 | 2025-09-30 | $537.0M | -$3.4M | -0.6% | -0.14 |
| Q2 FY 2025 | 2025-06-30 | $548.9M | $35.3M | 6.4% | 1.43 |
| Q1 FY 2025 | 2025-03-31 | $604.7M | -$15.5M | -2.6% | -0.63 |
| Q4 FY 2024derived | 2024-12-31 | $629.8M | -$23.8M | -3.8% | n/a |
| Q3 FY 2024 | 2024-09-30 | $589.1M | -$33.0M | -5.6% | -1.35 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.23B | $732K | $179.8M | $88.0M | $8.8M | n/a |
| FY 2024 | 2024-12-31 | $2.38B | -$117.7M | $204.0M | $79.4M | $12.0M | n/a |
| FY 2023 | 2023-12-31 | $2.26B | -$29.7M | $166.2M | $83.9M | $9.3M | n/a |
| FY 2022 | 2022-12-31 | $2.28B | -$74.3M | -$62.1M | $90.3M | $10.9M | n/a |
| FY 2021 | 2021-12-31 | $1.32B | $103.1M | $267.5M | $68.5M | $8.3M | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Icu Medical in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Icu Medical (ICUI), SEC CIK 883984, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-03.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-03.JSON and CSV
- Company record
- EDGAR filing index for CIK 883984Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of ICUI is sold short?
1,712,861 shares were held short at the 2026-10-15 settlement, 7.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ICUI's daily short volume?
On 2026-11-02, 64,627 of the 88,247 ICUI shares reported to FINRA were sold short, 73.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ICUI have fails to deliver?
The SEC's latest file shows 12 ICUI shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are ICUI insiders buying or selling?
Insiders at ICUI reported 13 open-market sells worth $6.6M in the last 90 days and no open-market buys. Latest filing: Sanzone Virginia Ruth (VP, General Counsel) on 2026-09-03.
Have ICUI insiders filed to sell?
13 Form 144 notices on file for ICUI worth $8.3M at the prices reported; 7 in the last 90 days worth $6.6M. Latest: VIRGINIA SANZONE filed on 2026-09-03 to sell 4,856 shares ($819K) from 2026-09-03.
Who owns 5% or more of ICUI?
4 holders report 5% or more of ICUI in their latest filing, all on Schedule 13G (passive). The largest reported stake is JANUS HENDERSON GROUP Ltd. at 11.1% of the class (2,781,621 shares), filed 2026-08-13 for an event on 2026-06-30.
What did ICUI report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Icu Medical reported revenue of $551.7M, up 0.5% from the same quarter a year earlier, and net income of $19.1M (0.76 diluted EPS). In FY 2025 it generated $179.8M of operating cash flow and spent $8.8M on buybacks.
Which tracked 13F managers own ICUI?
5 of the 30 tracked 13F managers held ICUI shares at their latest filing, $113.3M in all. The largest: Ken Griffin's Citadel Advisors (536K shares, $78.6M), Steve Cohen's Point72 Asset Management (165K shares, $24.3M), Cliff Asness's AQR Capital Management (44K shares, $6.5M), D. E. Shaw & Co. (20K shares, $2.9M), Izzy Englander's Millennium Management (7K shares, $970K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.